$ 68.68
Updated 10:06:32
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 5,186,742
High $ 70.00
Low $ 67.22
Open $ 70.00
ISIN
Prev close $ 70.08
# of shares 699.25M
Market cap 48,025M USD
Intraday

Market closed
Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  68.68 -5.2% Stock price decreasing -7.2% Stock price decreasing -21.3% Stock price decreasing -12.3% Stock price decreasing -36.4% Stock price decreasing
Powered by TradingView

News about Celgene Corporation

  • English
  • Regulatory news
10 Dec
 
31 Oct
 
27 Sep
 
14 Jun
 
29 May
 
25 May
 
23 May
 
22 May
 
22 May
 
22 May
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Shire PLC ORD 5P 4,498.50 -1.1% Stock price decreasing -2.5% Stock price decreasing 3.6% Stock price increasing 12.6% Stock price increasing 21.1% Stock price increasing 15.3% Stock price increasing
 
Bristol-Myers Squibb Company 52.58 1.1% Stock price increasing -1.5% Stock price decreasing -13.1% Stock price decreasing -1.0% Stock price decreasing -16.6% Stock price decreasing -14.2% Stock price decreasing
 
Johnson & Johnson 145,26 -0.5% Stock price decreasing -0.1% Stock price decreasing 4.9% Stock price increasing 18.4% Stock price increasing 2.9% Stock price increasing 4.0% Stock price increasing
 
Merck & Company Inc (new) 77.42 -1.0% Stock price decreasing 3.4% Stock price increasing 12.1% Stock price increasing 24.2% Stock price increasing 37.4% Stock price increasing 37.6% Stock price increasing
 
Pfizer Inc 44,40 -1.6% Stock price decreasing 0.3% Stock price increasing 4.9% Stock price increasing 22.3% Stock price increasing 22.6% Stock price increasing 22.6% Stock price increasing
 
Amgen Inc 194,09 -1.9% Stock price decreasing 0.5% Stock price increasing -2.7% Stock price decreasing 5.1% Stock price increasing 9.8% Stock price increasing 11.6% Stock price increasing
 
Gilead Sciences Inc 67.49 -3.0% Stock price decreasing -5.2% Stock price decreasing -6.6% Stock price decreasing -6.0% Stock price decreasing -11.1% Stock price decreasing -5.8% Stock price decreasing
 
Vertex Pharmaceuticals Incorpo.. 173.78 -2.3% Stock price decreasing -3.7% Stock price decreasing -2.7% Stock price decreasing 16.9% Stock price increasing 22.7% Stock price increasing 16.0% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,047.00 -2.6% Stock price decreasing -2.0% Stock price decreasing 5.5% Stock price increasing 12.6% Stock price increasing 24.0% Stock price increasing 18.1% Stock price increasing
 
Novartis AG 86.90 -4.3% Stock price decreasing -2.6% Stock price decreasing 3.5% Stock price increasing 14.6% Stock price increasing 3.7% Stock price increasing 3.5% Stock price increasing
 
Takeda PHARM.CO.LTD. 28.38 -12.4% Stock price decreasing -17.6% Stock price decreasing -19.0% Stock price decreasing -15.3% Stock price decreasing -39.3% Stock price decreasing -39.4% Stock price decreasing
 
Biogen Inc 319,44 -1.0% Stock price decreasing -1.8% Stock price decreasing -5.4% Stock price decreasing 4.2% Stock price increasing -2.6% Stock price decreasing 0.3% Stock price increasing
 
Roche Hldg Sp.Adr 1/8 27.75 -1.4% Stock price decreasing 3.6% Stock price increasing 6.8% Stock price increasing 24.6% Stock price increasing 8.3% Stock price increasing 5.6% Stock price increasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Shire PLC OR.. 4,498.50 0.0% Stock price decreasing
Bristol-Myer.. 52.58 -0.9% Stock price decreasing
Johnson & Jo.. 145,26 -0.1% Stock price decreasing
Merck & Comp.. 77.42 0.9% Stock price increasing
Pfizer Inc 44,40 1.1% Stock price increasing
Amgen Inc 194,09 0.0% Stock price unchanged
Gilead Scien.. 67.49 0.0% Stock price unchanged
100,39,44,29,11,4,8,10,19,12
Vertex Pharm.. 173.78 0.0% Stock price unchanged
Astrazeneca .. 6,047.00 0.7% Stock price increasing
Novartis AG 86.90 -0.2% Stock price decreasing
Takeda PHARM.. 28.38 -3.0% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Biogen Inc 319,44 0.0% Stock price unchanged
Roche Hldg S.. 27.75 -1.4% Stock price decreasing

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 10:22:34
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB7 - 2018-12-11 11:22:34 - 2018-12-11 10:22:34 - 1000 - Website: OKAY